OrbiMed, Thiel lead ChemomAb's $10M series B

Antibody company ChemomAb Ltd. (Tel Aviv, Israel) raised $10 million in a series B round led by OrbiMed Israel and Peter Thiel. SBI Japan-Israel Innovation Fund and Milestone Venture also participated. The company previously raised $5 million in a venture round from OrbiMed Israel and private investors...